12:00 AM
Jun 26, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Demegen preclinical data

In a 14-day study of rats with full-thickness burn wounds, topical D2A21 administration gave 85 percent survival compared to no survivors in the control group....

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >